OR WAIT null SECS
© 2021 MJH Life Sciences and Applied Clinical Trials Online. All rights reserved.
© 2021 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
April 22, 2021
While many voices are in agreement that the drive for diversity is both necessary and achievable—the question still remains: How do we actually start creating those meaningful conversations?
March 09, 2021
Understanding the role of social determinants on clinical trial participation and trust.
February 12, 2021
Co-conveners of the newly formed Decentralized Trials & Research Alliance, Amir Kalali, MD and Craig Lipset discuss the alliance as well as how COVID-19 has impacted the industry.
Hybrid studies, patient-centric tools, and collaborations create big changes for clinical trials and stakeholders during COVID-19.
December 16, 2020
EVP and General Manager of Hū, April Lewis, discusses why the industry has seen a decline in trial participation and what Hū is doing to combat it.
Eliminating barriers to engage underrepresented populations.
October 23, 2020
Randomized controlled trials establish strict inclusion and exclusion criteria in an effort to optimize the cohort of trial participants.
October 16, 2020
Recognizing pre-pandemic pain points, such as patient engagement and protocol development, could lead to post-pandemic trial success.
Evaluating the lessons learned about trial sites from COVID-19 to form new strategies and improve patient safety for the future.
With the assistance of mobile research nursing, in-home visits provide solid alternative to trial participants, especially during COVID-19.